Prof. Dr. Thomas Knittel

Prof. Dr. Thomas Knittel is an experienced medical and pharmaceutical professional currently serving on the Supervisory Board of HepaRegeniX GmbH since November 2017 and as the Chief Medical Officer of Index Pharmaceuticals AB since January 2012. A notable past position includes Chief Medical Officer at EPM Group Inc. from September 2021 to June 2022. Additionally, Prof. Dr. Knittel held roles such as Managing Director at Medoderm GmbH, General Manager Pharmaceuticals at Harlan Laboratories, and Business Unit Director at Novo Nordisk, where oversight included marketing, sales, and medical departments. Prior experience includes Vice President Corporate and Medical Affairs at Develogen AG and an academic career as Associate Professor at University Clinic Göttingen. Educational qualifications include an MBA in Economics from Kellogg School of Management/WHU and a Medical Doctor degree from Johannes Gutenberg University Mainz.